Chronic kidney disease mineral bone disorder (CKD-MBD) is a common co-morbidity in
patients with CKD. Characterized by laboratory abnormalities, bone abnormality, and …

Cardiovascular (CV) disease (CVD) accounts for> 50% of deaths with known causes in
patients on dialysis. Elevated serum phosphorus levels are an important nontraditional risk …

Plasma approaches metastability with respect to its calcium and phosphate content, with
only minor perturbations in ionic activity needed to sustain crystal growth once nucleated …

Background: Chronic kidney disease (CKD) affects approximately 15% of adults in the USA.
As CKD progresses, urinary phosphate excretion decreases and results in phosphate …

Background Reducing intestinal phosphorus absorption is a cornerstone in CKD-MBD
management. Yet, knowledge gaps include how CKD pathophysiology affects intestinal …

Chronic kidney disease (CKD) is associated with a mineral and bone disorder (CKD-MBD)
which starts early in the course of the disease and worsens with its progression. The main …

Novel intestinal dialysis interventions and microbiome modul... : Current Opinion in Nephrology
and Hypertension Novel intestinal dialysis interventions and microbiome modulation to control …

Chronic kidney disease (CKD) affects 9.1% of the population worldwide. CKD may lead to
structural and functional gastrointestinal alterations, including impairment in the intestinal …

Intestinal phosphorus absorption: recent findings in transla... : Current Opinion in Nephrology
and Hypertension Intestinal phosphorus absorption: recent findings in translational and clinical …

Because of increased risks of cardiovascular disease and death, patients with
hyperphosphatemia receiving maintenance dialysis are advised to limit phosphorus …